Question Bank › The knock on the company is going stale

The knock on the company is going stale

The knock on the company is going stale: this quarter's own facts cut against the standing doubt

Calls Tested
287
Answered YES
68
Hit Rate
23.7%
rare by design

Pool Corporation (POOL) — this company's answers

NO on the Q4 2022 call 2023-02-16 C+
The model's full reasoning — Q4 2022 call → NO我们根据要求,需要判断是否有一个明确的、公司特定的疑虑,并且当前期间的实际运营证据是否反驳了该疑虑。从电话会议中,我们看到分析师和公司管理层讨论了多个话题,如新泳池建设下降、通货膨胀、供应链正常化、市场份额等。但我们需要找到一个“standing doubt”——一个长期存在的、公司特定的担忧,并且当前证据与之相反。 可能的疑虑:新泳池建设下降?但这是行业性的,不是公司特定的。或者关于毛利率下降?但那是预期中的。或者关于欧洲业务?但那是区域性的。或者关于Horizon业务?但管理层表示其表现良好。或者关于化学产品进口关税?但那是非经常性的。 仔细阅读,分析师多次询问关于新泳池建设、市场份额、毛利率等,但似乎没有明显的“standing doubt”被反复提及。管理层在回答中提到了“我们相信2023年将是坚实的一年”,但这是展望。当前期间的实际证据:第四季度收入增长6%,全年增长17%,毛利率全年增长80个基点,但第四季度毛利率下降230个基点(部分由于关税)。管理层提到“我们继续获得市场份额”,但这是陈述而非具体证据。 也许疑虑是关于“新泳池建设下降”是否会影响公司?但管理层给出了具体数字:2022年新泳池建设约98,000个,下降16%,而公司的新建业务下降12-13%,表明公司表现优于行业。这可能是反驳。但这是否是“standing doubt”?分析师可能担心新泳池建设下降会拖累公司,但管理层用实际数据表明公司份额增加。 另一个可能的疑虑:关于供应链正常化后,客户购买习惯改变,是否会影响销售?管理层提到第四季度零售客户发货增长1%,但全年增长9%,并解释这是正常化。但这不是长期疑虑。 或者关于毛利率的可持续性?管理层解释毛利率下降是价格成本回吐,但全年仍增长。 我认为最接近的是:分析师可能担心新泳池建设下降会严重影响公司,但管理层用实际数据(公司新建业务下降幅度小于行业)来反驳。但这是否是“standing doubt”?在电话会议中,分析师多次询问新泳池建设,但管理层给出了预期和实际数据。然而,这更多是行业趋势,而非公司特定疑虑。 另一个可能:关于欧洲业务下滑,管理层承认欧洲销售下降22.5%,但表示长期增长机会。这似乎是确认疑虑而非反驳。 或者关于Horizon业务?管理层表示其表现良好,但分析师没有特别质疑。 也许疑虑是关于公司能否维持高增长?但管理层给出了2023年指引,但那是展望。 再读一遍,分析师Ryan Merkel问“volume assumption”,管理层详细解释。分析师David Manthey问“pre-buy”水平,管理层回答。分析师Susan Maklari问竞争动态,管理层回答。分析师Andrew Carter问关税和SG&A,管理层回答。分析师Joe Ahlersmeyer问第一季度销售和毛利率,管理层回答。分析师Noah问维护业务,管理层回答。分析师Joseph问自由现金流,管理层回答。分析师Shaun问市场份额,管理层回答。分析师Jeffrey问三氯价格,管理层回答。 似乎没有一个明确的、反复出现的公司特定疑虑。所有问题都是关于当前业绩和未来展望,但管理层都给出了具体数据和解释。没有迹象表明有一个长期存在的疑虑被反复提及。 也许疑虑是关于“新泳池建设下降”是否会导致公司收入下降?但管理层给出了具体数据表明公司表现优于行业。但这是否是“standing doubt”?在电话会议中,分析师没有明确说“我们担心新泳池建设下降”,而是直接问假设。管理层也给出了预期。 另一个可能:关于毛利率下降,分析师问“毛利率下降原因”,管理层解释。但这不是长期疑虑。 我认为没有明确的“standing doubt”。因此答案应为NO。 但让我们再仔细看:管理层在开头说“2022年又是非凡的一年”,然后提到“我们继续扩大市场份额”。分析师问“竞争动态”,管理层回答。分析师问“新泳池建设”,管理层给出数据。似乎没有分析师表达担忧,而是询问细节。 也许疑虑是关于“公司能否在供应链正常化后保持增长”?但管理层用实际数据表明第四季度仍增长6%。 或者疑虑是关于“化学产品进口关税”的影响?但那是非经常性的。 我认为没有符合要求的疑虑。因此答案NO。

← Back to the full POOL analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: Reading this call as a whole, can you identify ONE well-defined DOUBT that has clearly been weighing on how this company is perceived — a standing knock evident from the transcript itself, such as skepticism that its losses will ever end, that its main product or model will find repeat demand, that its legacy business's decline will swamp everything else, that it depends too heavily on one customer, market, or financing source, or another comparable company-specific concern — AND does the CURRENT PERIOD'S OWN OPERATING EVIDENCE, as recounted by management, move clearly AGAINST that doubt? Answer YES when BOTH halves come through in the transcript, in whatever form fits the business: (1) A STANDING, COMPANY-SPECIFIC DOUBT IS VISIBLE ON THE CALL. The transcript itself shows that a particular concern has hung over this company — through analysts returning to it, management acknowledging what skeptics or investors have worried about, or management plainly addressing a question it knows the audience carries (can this business make money, will anyone buy this at scale, will the decline stop, can they fund themselves, will the big customer stay). The doubt must be specific to this company's situation, not generic macro gloom, and must read as something that predates this quarter rather than arising on this call. (2) THIS PERIOD'S REAL ACTIVITY CUTS AGAINST IT. Management recounts concrete things that actually happened in the recent period — actual orders, customers returning or expanding, real revenue or volumes where there had been little, losses narrowing because of how the business itself is now running, the doubted product performing in real use, the feared departure or decline not occurring while something better did — described with enough operating substance that the contradiction rests on observed events rather than on reassurance, plans, or projections. The evidence need not fully settle the doubt; what matters is that the current period's facts point the other way and management engages the doubt with those facts. Answer NO if no company-specific doubt is discernible — an ordinarily healthy company reporting a routine quarter. NO if the doubt exists but management answers it mainly with confidence, vision, targets, or hoped-for improvements rather than with things that already happened. NO if the period's evidence actually confirms the doubt (the losses widened, the decline continued, the customer left) and management is excusing it. NO if the contrary evidence is a one-time item, an asset sale, a financing, or something management itself treats as non-recurring rather than the business operating differently. NO if the doubt and the evidence never connect — strong facts reported on one topic while the standing concern sits elsewhere untouched. NO if the doubt appears only as boilerplate risk language or an analyst aside that management never engages. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
CRGO Freightos Limited Q1 2024 2024-05-20 C+
IFS Intercorp Financial Services Inc. Q1 2024 2024-05-14 C+
PRA ProAssurance Corporation Q1 2024 2024-05-11 D
LTRX Lantronix, Inc. Q3 2024 2024-04-29 C
ASB Associated Banc-Corp Q1 2024 2024-04-25 A
GL Globe Life Inc. Q1 2024 2024-04-23 F
ASM Avino Silver & Gold Mines Ltd. Q4 2023 2024-03-21 C+
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
HP Helmerich & Payne, Inc. Q1 2024 2024-01-30 C
PFE Pfizer Inc. Q4 2023 2024-01-30 F
QTRX Quanterix Corporation Q3 2023 2023-11-07 B
ALL The Allstate Corporation Q3 2023 2023-11-02 C+
DASH DoorDash, Inc. Q3 2023 2023-11-01 C+
PTN Palatin Technologies, Inc. Q4 2023 2023-09-29 D
BZUN Baozun Inc. Q2 2023 2023-08-28 D
GVP GSE Systems, Inc. Q1 2023 2023-05-15 D
BXSL Blackstone Secured Lending Fund Q1 2023 2023-05-10 A
FTHM Fathom Holdings, Inc. Q1 2023 2023-05-10 C
SPIR Spire Global, Inc. Q1 2023 2023-05-10 B
SBRA Sabra Health Care REIT, Inc. Q1 2023 2023-05-04 B
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
VRE Veris Residential, Inc. Q4 2022 2023-02-22 D
TOST Toast, Inc. Q4 2022 2023-02-16 C+
PKOH Park-Ohio Holdings Corp. Q3 2022 2022-11-13 B
CLSD Clearside Biomedical, Inc. Q3 2022 2022-11-09 C
SIBN SI-BONE, Inc. Q3 2022 2022-11-07 C+
CHE Chemed Corporation Q3 2022 2022-11-01 B+
YMM Full Truck Alliance Co. Ltd. Q2 2022 2022-08-25 C+
EXFY Expensify, Inc. Q2 2022 2022-08-12 D
WD Walker & Dunlop, Inc. Q2 2022 2022-08-09 C+
DM Desktop Metal, Inc. Q2 2022 2022-08-08 F
XHR Xenia Hotels & Resorts, Inc. Q2 2022 2022-08-05 A
LIN Linde plc Q2 2022 2022-07-28 B+
CME CME Group Inc. Q2 2022 2022-07-27 B
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
SE Sea Limited Q1 2022 2022-05-17 F
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
OPK OPKO Health, Inc. Q1 2022 2022-05-09 D
FARM Farmer Bros. Co. Q3 2022 2022-05-07 D
BFIN BankFinancial Corporation Q1 2022 2022-05-06 A
BXP Boston Properties, Inc. Q1 2022 2022-05-03 A
STC Stewart Information Services Corporation Q1 2022 2022-04-29 C+
LOW Lowe's Companies, Inc. Q3 2021 2021-11-17 B+
CYBR CyberArk Software Ltd. Q3 2021 2021-11-04 B+
IPGP IPG Photonics Corporation Q3 2021 2021-11-02 C
SXC SunCoke Energy, Inc. Q3 2021 2021-11-01 A
EMR Emerson Electric Co. Q3 2021 2021-08-04 B+
EEX Emerald Holding, Inc. Q2 2021 2021-08-01 C+
GECC Great Elm Capital Corporation Q3 2018 2018-11-13 B
UMH UMH Properties, Inc. Q3 2018 2018-11-02 C+
FOSL Fossil Group, Inc. Q1 2018 2018-05-08 C
BCOV Brightcove Inc. Q1 2018 2018-04-26 B+
AVT Avnet, Inc. Q2 2018 2018-01-25 B
PII Polaris Inc. Q3 2017 2017-10-24 C+
GNTX Gentex Corporation Q3 2017 2017-10-20 B
MTG MGIC Investment Corporation Q3 2017 2017-10-18 B+
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C
BIIB Biogen Inc. Q2 2017 2017-07-25 B
CAG Conagra Brands, Inc. Q2 2017 2016-12-22 C+
WYY WidePoint Corporation Q3 2016 2016-11-09 D
ULBI Ultralife Corporation Q3 2016 2016-10-29 C+
ARAY Accuray Incorporated Q4 2016 2016-08-17 B
GES Guess?, Inc. Q1 2017 2016-05-25 F
RCL Royal Caribbean Cruises Ltd. Q1 2016 2016-04-29 C+
DD DuPont de Nemours, Inc. Q1 2016 2016-04-26 B+
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C

How the model reasoned

BRX · Q1 2023 → YESThe question asks if there's a standing company-specific doubt visible on the call, and if this period's operating evidence cuts against it. YES The standing doubt is the skepticism that tenant disruptions (especially bankruptcies like Bed Bath) will create occupancy pressure and throw markets out of equilibrium, given the recaptured space and potential for more filings. This is visible in analyst questions (Todd Thomas on Bed Bath impact and market equilibrium; others circling back on bad debt 75-110 bps and bankruptcy activity) and management's acknowledgment that "recent retailer bankruptcy announcements will result in occupancy pressure" while noting they've "been preparing for the last several quarters." This period's evidence cuts against it: record 94% total occupancy (up sequentially in a seasonally weak quarter), small-shop at 89.
CME · Q2 2022 → YESThe question is: Identify ONE well-defined DOUBT that has been weighing on the company, and see if the current period's operating evidence moves against that doubt. YES The standing doubt is the perceived risk that the legacy NEX Group businesses (BrokerTec and EBS) would continue to show range-bound revenue and fail to deliver meaningful growth despite a constructive macro backdrop, as directly raised by Alex Blostein. Management engages this concern head-on by recounting concrete operating evidence from 2Q: BrokerTec US treasuries ADV up 14% YoY, US repo up 25% YoY, EU repo up 14% YoY, plus $4.5 billion in new cross-sell volume from previously non-trading clients and record RV trading volumes of $2.4 billion; 90% of the migration to Globex is complete, with the remaining EBS migration also finished and system enhancements underway.
BXSL · Q1 2023 → YESThe question asks if there's a standing company-specific doubt visible in the transcript, and if this period's operating evidence moves against it. YES The standing doubt visible in the transcript is the skepticism that BXSL’s credit performance will be materially worse than the broader private-credit market because of its exposure to higher-rate environments and the “tails” of the portfolio (i.e., the small slice of companies whose interest-coverage ratios could fall below 1× when 5 % rates are stress-tested). Management itself flags this concern by noting that “it is less about averages… much more about the tails” and that investors keep asking about the percentage of the portfolio below 1× ICR. This quarter’s operating evidence directly counters that doubt: - 0.

More from the question bank

Acted like it's already biggerBetting on a claim they haven't proven yetMoney already collected for work not yet donNew faces on the callThe streak is aliveCommitted past the numbersAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.